These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 23532848)

  • 1. Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity.
    Salzmann S; Seher A; Trebing J; Weisenberger D; Rosenthal A; Siegmund D; Wajant H
    J Biol Chem; 2013 May; 288(19):13455-66. PubMed ID: 23532848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity.
    Zaitseva O; Hoffmann A; Löst M; Anany MA; Zhang T; Kucka K; Wiegering A; Otto C; Wajant H
    Front Immunol; 2023; 14():1194610. PubMed ID: 37545514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14).
    Fick A; Lang I; Schäfer V; Seher A; Trebing J; Weisenberger D; Wajant H
    J Biol Chem; 2012 Jan; 287(1):484-495. PubMed ID: 22081603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
    Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
    J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.
    Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N
    J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyzing the signaling capabilities of soluble and membrane TWEAK.
    Trebing J; Arana JA; Salzmann S; Wajant H
    Methods Mol Biol; 2014; 1155():31-45. PubMed ID: 24788171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD.
    Chopra M; Brandl A; Siegmund D; Mottok A; Schäfer V; Biehl M; Kraus S; Bäuerlein CA; Ritz M; Mattenheimer K; Schwinn S; Seher A; Grabinger T; Einsele H; Rosenwald A; Brunner T; Beilhack A; Wajant H
    Blood; 2015 Jul; 126(4):437-44. PubMed ID: 26012567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.
    Brown SA; Cheng E; Williams MS; Winkles JA
    PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.
    Campbell S; Burkly LC; Gao HX; Berman JW; Su L; Browning B; Zheng T; Schiffer L; Michaelson JS; Putterman C
    J Immunol; 2006 Feb; 176(3):1889-98. PubMed ID: 16424220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.
    Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL
    Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
    Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
    Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death.
    Haile WB; Echeverry R; Wu F; Guzman J; An J; Wu J; Yepes M
    Neuroscience; 2010 Dec; 171(4):1256-64. PubMed ID: 20955770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an Fn14 agonistic antibody as an anti-tumor agent.
    Michaelson JS; Amatucci A; Kelly R; Su L; Garber E; Day ES; Berquist L; Cho S; Li Y; Parr M; Wille L; Schneider P; Wortham K; Burkly LC; Hsu YM; Joseph IB
    MAbs; 2011; 3(4):362-75. PubMed ID: 21697654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TWEAK-Fn14 system as a potential drug target.
    Wajant H
    Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWEAK signals through JAK-STAT to induce tumor cell apoptosis.
    Chapman MS; Wu L; Amatucci A; Ho SN; Michaelson JS
    Cytokine; 2013 Jan; 61(1):210-7. PubMed ID: 23107828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor.
    Polek TC; Talpaz M; Darnay BG; Spivak-Kroizman T
    J Biol Chem; 2003 Aug; 278(34):32317-23. PubMed ID: 12794080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death.
    Nakayama M; Ishidoh K; Kojima Y; Harada N; Kominami E; Okumura K; Yagita H
    J Immunol; 2003 Jan; 170(1):341-8. PubMed ID: 12496418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Src homology 3 domain-containing guanine nucleotide exchange factor is overexpressed in high-grade gliomas and promotes tumor necrosis factor-like weak inducer of apoptosis-fibroblast growth factor-inducible 14-induced cell migration and invasion via tumor necrosis factor receptor-associated factor 2.
    Fortin Ensign SP; Mathews IT; Eschbacher JM; Loftus JC; Symons MH; Tran NL
    J Biol Chem; 2013 Jul; 288(30):21887-97. PubMed ID: 23775076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fn14·TRAIL fusion protein is oligomerized by TWEAK into a superefficient TRAIL analog.
    Prigozhina TB; Szafer F; Aronin A; Tzdaka K; Amsili S; Makdasi E; Shani N; Dranitzki Elhalel M
    Cancer Lett; 2017 Aug; 400():99-109. PubMed ID: 28455246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis.
    Dohi T; Kawashima R; Kawamura YI; Otsubo T; Hagiwara T; Amatucci A; Michaelson J; Burkly LC
    Cytokine; 2014 Sep; 69(1):14-21. PubMed ID: 25022957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.